top of page
Browse by category
Search
OMMs appear to be valid alternatives to EBP and MBS for mild-to-moderate obesity, but surgery more effective for patients with a higher degree of obesity
For patients living with mild-to-moderate obesity, newer obesity management medications (OMM) such as tirzepatide and semaglutide, appear to be valid alternatives to endoscopic bariatric procedures (EBP) and metabolic bariatric surgery (MBS), according to researchers from the Italian Obesity Society (Società Italiana dell'Obesità (SIO)). Their study reveals the results from a systematic review (SR) and a network meta-analysis (NMA) on randomised clinical trials (RCTs) compari
Weight loss treatments for people with diabetes and obesity could lower the risk of obesity-associated cancers
Weight loss treatments, including medication and surgical procedures, may help lower the risk of obesity-associated cancers (OAC) in...
Significant disparities in the availability of MBS services and the level of resident training and exposure
A global survey on general surgery resident involvement in metabolic and bariatric surgery (MBS) has reported that significant...
The role of obesity management medications and metabolic and bariatric surgery – an IFSO Consensus Meeting (Module III)
Module III: The future Obesity management medications & metabolic surgery perspectives on cost-effectiveness In the first presentation in...
The role of obesity management medications and metabolic and bariatric surgery – an IFSO Consensus Meeting (Module II)
Module II: Use of OMMs after MBS Combined medical-surgical treatment of obesity In the first presentation of the second module by...
Browse by tag
bottom of page